Cannatonic

Cannatonic stands out as a well-balanced hybrid combining equal parts Indica and Sativa genetics, prized for its notably elevated CBD concentration of 12%. This composition delivers therapeutic benefits for numerous conditions while minimizing intense psychoactive effects. Bred from MK Ultra and G 13 Haze parentage, this strain has demonstrated promise for managing symptoms associated with multiple sclerosis, epilepsy, and Parkinson's disease.

The flavor profile combines ground-forward undertones with bright citrus elements, finishing with subtle tangy-sweet notes when consumed. Beyond its appeal for recreational users seeking mild euphoria, Cannatonic excels at addressing chronic pain, swelling, and tension headaches without causing drowsiness. Indoor cultivation yields approximately 500 grams per square meter over a 10-11 week flowering cycle, though growers should remain vigilant against fungal issues.

Outdoor production typically generates around 14 ounces per plant, with harvesting occurring in October. The strain's therapeutic potential makes it particularly valuable for medical cannabis users prioritizing symptom relief with mental clarity.